Zobrazeno 1 - 10
of 651
pro vyhledávání: '"A. K. Ray-Chaudhuri"'
Autor:
Fen Xie, Bibiao Shen, Yuqi Luo, Hang Zhou, Zhenchao Xie, Shuzhen Zhu, Xiaobo Wei, Zihan Chang, Zhaohua Zhu, Changhai Ding, Kunlin Jin, Chengwu Yang, Lucia Batzu, K Ray Chaudhuri, Ling-Ling Chan, Eng-King Tan, Qing Wang
Publikováno v:
Molecular Neurodegeneration, Vol 19, Iss 1, Pp 1-22 (2024)
Abstract Background Repetitive transcranial magnetic stimulation (rTMS) has been used to treat various neurological disorders. However, the molecular mechanism underlying the therapeutic effect of rTMS on Parkinson’s disease (PD) has not been fully
Externí odkaz:
https://doaj.org/article/5b83025f6a614b0b83870b9d2475bad8
Autor:
Angelo Antonini, K. Ray Chaudhuri, Josefa Domingos, Joohi Jimenez-Shahed, Jack Wright, Connie H. Yan, Ali Alobaidi, Lars Bergmann, Koray Onuk, Linda Harmer, Irene A. Malaty
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-4 (2024)
Abstract The 5-2-1 criteria was developed to facilitate the identification and referral of patients with Parkinson’s Disease (PD) inadequately controlled by oral medications. The criterion was not developed to screen patients with PD for device-aid
Externí odkaz:
https://doaj.org/article/883ecde81a8b417fa8d4333cdc41ef4f
Publikováno v:
Neurology and Therapy, Vol 13, Iss 4, Pp 1055-1068 (2024)
Abstract The management of Parkinson’s disease (PD) continues to evolve with advancements in non-oral levodopa-based therapies aiming to provide continuous drug delivery (CDD). Such therapies address the challenges posed by the emergence of motor f
Externí odkaz:
https://doaj.org/article/edd550052ccd4efdb93128992956c14f
Autor:
Anna Sauerbier, Johanna Herberg, Vasilija Stopic, Philipp A. Loehrer, Keyoumars Ashkan, Alexandra Rizos, Stefanie T. Jost, Jan Niklas Petry-Schmelzer, Alexandra Gronostay, Christian Schneider, Veerle Visser-Vandewalle, Julian Evans, Christopher Nimsky, Gereon R. Fink, Angelo Antonini, Pablo Martinez-Martin, Monty Silverdale, Daniel Weintraub, Anette Schrag, K. Ray Chaudhuri, Lars Timmermann, Haidar S. Dafsari, EUROPAR, the German Parkinson Society Non-motor Symptoms Study Group, and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract The effects of subthalamic nucleus deep brain stimulation (STN-DBS) on anxiety in Parkinson’s disease (PD) are understudied. We identified clinical predictors of STN-DBS effects on anxiety in this study. In this prospective, open-label, mu
Externí odkaz:
https://doaj.org/article/a6902ba4ec7743e9995a8a15e10c4574
Autor:
Philipp Alexander Loehrer, Wibke Schumacher, Stefanie T. Jost, Monty Silverdale, Jan Niklas Petry-Schmelzer, Anna Sauerbier, Alexandra Gronostay, Veerle Visser-Vandewalle, Gereon R. Fink, Julian Evans, Max Krause, Alexandra Rizos, Angelo Antonini, Keyoumars Ashkan, Pablo Martinez-Martin, Christian Gaser, K. Ray Chaudhuri, Lars Timmermann, Juan Carlos Baldermann, Haidar S. Dafsari, On behalf of EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson’s Disease Study Group
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-8 (2024)
Abstract Deep brain stimulation of the subthalamic nucleus (STN-DBS) is an established therapy in advanced Parkinson’s disease (PD). Motor and non-motor outcomes, however, show considerable inter-individual variability. Preoperative morphometry-bas
Externí odkaz:
https://doaj.org/article/fead6b46e24747899eca1c4112f5d928
Autor:
Cristian Falup-Pecurariu, Alessandra Fanciulli, Rupam Borgohain, Vinod Metta, K. Ray Chaudhuri
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/880b2d8231164f9091fe2bb4a7ecdc86
Autor:
K. Ray Chaudhuri, Jean-Philippe Azulay, Per Odin, Susanna Lindvall, Josefa Domingos, Ali Alobaidi, Prasanna L. Kandukuri, Vivek S. Chaudhari, Juan Carlos Parra, Toru Yamazaki, Julia Oddsdottir, Jack Wright, Pablo Martinez-Martin
Publikováno v:
Drugs - Real World Outcomes, Vol 11, Iss 1, Pp 1-11 (2024)
Abstract Background Parkinson’s disease is now one of the fastest-growing neurodegenerative disorders in the developed world, with an increasing prevalence and associated socioeconomic costs. Progression of the disease leads to a gradual deteriorat
Externí odkaz:
https://doaj.org/article/103824b4d83b4f0c8202e09b41a95844
Autor:
Aleksandra M. Podlewska, Lucia Batzu, Tayana Soukup, Nick Sevdalis, Ioannis Bakolis, Fleur Derbyshire-Fox, Alison Hartley, Andy Healey, Anthony Woods, Nikki Crane, Carmine Pariante, K Ray Chaudhuri
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background To date, beneficial effects of multimodal exercise programmes on Parkinson’s disease (PD) have focused on motor symptoms and little attention has been paid to the potential effects of such programmes on the non-motor symptoms of
Externí odkaz:
https://doaj.org/article/ff5f74c61d474e60ac6d827dd7a8ddb0
Autor:
Benedetta Tafuri, Daniele Urso, Salvatore Nigro, Luigi Macchitella, Roberto De Blasi, K. Ray Chaudhuri, Giancarlo Logroscino
Publikováno v:
npj Parkinson's Disease, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Loss of empathy is an early and central symptom of frontotemporal lobar degeneration spectrum diseases. We aimed to investigate the topographical distribution of morphometric brain changes associated with empathy in Progressive Supranuclear
Externí odkaz:
https://doaj.org/article/1b79ad8eea024c0c8cbb716818ff531a
Autor:
Jason Aldred, Eric Freire-Alvarez, Alexander V. Amelin, Angelo Antonini, Bruno Bergmans, Filip Bergquist, Manon Bouchard, Kumar Budur, Camille Carroll, K. Ray Chaudhuri, Susan R. Criswell, Erik H. Danielsen, Florin Gandor, Jia Jia, Thomas E. Kimber, Hideki Mochizuki, Weining Z. Robieson, Amy M. Spiegel, David G. Standaert, Saritha Talapala, Maurizio F. Facheris, Victor S. C. Fung
Publikováno v:
Neurology and Therapy, Vol 12, Iss 6, Pp 1937-1958 (2023)
Abstract Introduction Foslevodopa/foscarbidopa, a soluble formulation of levodopa/carbidopa (LD/CD) prodrugs for the treatment of Parkinson’s disease (PD), is administered as a 24-hour/day continuous subcutaneous infusion (CSCI) with a single infus
Externí odkaz:
https://doaj.org/article/3c28527413ce4845845ba7b0a3dbeb25